$1.29-0.34 (-20.86%)
Ping An Biomedical Co. Ltd. (PASW) is an Apparel company listed on NASDAQ. In the last 30 days Quantisnow tracked 9 wire items for PASW, including 5 SEC filings and 4 press releases and news items. The most recent was published Nov 5, 2026.
Price$1.29-3.87 (-75.00%)
2026-08-062026-11-06
Financial highlights
Full financials- Revenue, FY2025
- CN¥34.15M
- Revenue growth
- -61.0%
- Net income, FY2025
- -CN¥12.83M
- Net margin
- -37.6%
- Cash
- CN¥1.17M
For fiscal 2025 (ended Sep 30, 2025), from SEC filings. Not investment advice.
News · 26 weeks14+100%
2026-05-172026-11-08
Mix1090d
- SEC Filings6(60%)
- Other4(40%)
Activity · 52 weeks3124 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- SECSEC Form 6-K filed by Ping An Biomedical Co. Ltd.6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
- PRPing An Biomedical Enters into Patent Purchase Agreement with Future Biotechnology Group for Tumor Cell TechnologiesHONG KONG, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (NASDAQ:PASW) (the "Company") today announced that it has entered into a definitive purchase agreement (the "Agreement") with Future Biotechnology Group Co., Limited for the acquisition (the "Acquisition") of three tumor cell-related medical technology patents covering areas including oncology diagnosis and treatment, cell detection and bioengineering, and biomarker and DNA probe technologies, for a consideration of US$2.3 million. The Agreement follows the Company’s previously announced letter of intent dated October 22, 2026. The Acquisition is intended to support the Company’s longer-term healthcare and biomedical
- SECSEC Form 6-K filed by Ping An Biomedical Co. Ltd.6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
- SECSEC Form 6-K filed by Ping An Biomedical Co. Ltd.6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
- SECSEC Form F-3 filed by Ping An Biomedical Co. Ltd.F-3 - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
- SECSEC Form 6-K filed by Ping An Biomedical Co. Ltd.6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
- PRPing An Biomedical Announces Planned Acquisition of Three Tumor Cell-Related Medical Technology Patents to Build a Core Oncology and Biotech Intellectual Property PortfolioHONG KONG, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (NASDAQ:PASW) (the "Company") today announced its entry into a letter of intent with Future Biotechnology Group Co., Limited (the "Letter of Intent"), for the planned acquisition (the "Planned Acquisition") of three tumor cell-related medical technology patents covering areas including oncology diagnosis and treatment, cell detection and bioengineering, and biomarker and DNA probe technologies, for a consideration ranging from US 2 million to US 2.5 million. The Planned Acquisition shall be subject to a final acquisition agreement to be subsequently prepared and executed by the parties. The Planned Acquisition is int
- SECSEC Form 6-K filed by Ping An Biomedical Co. Ltd.6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
- PRPing An Biomedical Announces 1-for-40 Reverse Stock SplitHONG KONG, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (NASDAQ:PASW) ("Ping An Bio" or the "Company") announced that its board of directors has approved a 1-for-40 reverse stock split of the Company’s class A ordinary shares and class B ordinary shares. The Company’s class A ordinary shares are expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market at the opening of trading on October 23, 2026. The shares will continue to trade under the ticker symbol "PASW." At the extraordinary general meeting (the "EGM") of shareholders of the Company held on 18 March 2026, at 9:00 a.m., Hong Kong Time, the following matters, among others, were approved and
- SECSEC Form 6-K filed by Ping An Biomedical Co. Ltd.6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
- SECSEC Form 6-K filed by Ping An Biomedical Co. Ltd.6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
- SECSEC Form 6-K filed by Ping An Biomedical Co. Ltd.6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
- SECSEC Form 6-K filed by Ping An Biomedical Co. Ltd.6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
- SECSEC Form 6-K filed by Ping An Biomedical Co. Ltd.6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
- INSIDERSEC Form 3 filed by new insider Liu Pijun (Pjl)3 - Ping An Biomedical Co., Ltd. (0001897532) (Issuer)
- INSIDERSEC Form 3 filed by new insider Liu Xianzhi (Xzl)3 - Ping An Biomedical Co., Ltd. (0001897532) (Issuer)
- INSIDERSEC Form 3 filed by new insider Yang Hongli (Hly)3 - Ping An Biomedical Co., Ltd. (0001897532) (Issuer)
- SECSEC Form 6-K filed by Ping An Biomedical Co. Ltd.6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
- PRAll Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share CapitalHONG KONG, March 19, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ:PASW) (hereinafter referred to as "Ping An Bio") announced that shareholders have approved all five resolutions at the company's 2026 Annual General Meeting, providing full authorization for an overhaul of its share capital structure, the introduction of high‑vote Class B shares, a targeted share exchange with a major shareholder, and a large‑scale share consolidation. Authorised Share Capital Changes Shareholders resolved by an ordinary resolution that, the Company authorised share capital of the Company be amended in the manner and sequence set out below with immediate effect (collectively, the Authorise
- INSIDERSEC Form 3 filed by Ping An Biomedical Co. Ltd.3 - Ping An Biomedical Co., Ltd. (0001897532) (Issuer)
- INSIDERSEC Form 3 filed by Ping An Biomedical Co. Ltd.3 - Ping An Biomedical Co., Ltd. (0001897532) (Issuer)
- SECSEC Form 6-K filed by Ping An Biomedical Co. Ltd.6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
- SECSEC Form EFFECT filed by Ping An Biomedical Co. Ltd.EFFECT - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
- SECSEC Form F-1 filed by Ping An Biomedical Co. Ltd.F-1 - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
- SECSEC Form 6-K filed by Ping An Biomedical Co. Ltd.6-K - Ping An Biomedical Co., Ltd. (0001897532) (Filer)
PASW FAQ
9 questionsWhat is the latest news on PASW?
In the last 30 days Quantisnow tracked 9 wire items for PASW: 5 SEC filings and 4 press releases and news items. The most recent was published on November 5, 2026.What is PASW revenue?
Ping An Biomedical Co. Ltd. (PASW) reported CN¥34.15M of revenue for fiscal 2025 (ended Sep 30, 2025). That is down 61.0% from the year before.Is PASW profitable?
No. Ping An Biomedical Co. Ltd. reported a net loss of CN¥12.83M for fiscal 2025 (ended Sep 30, 2025).How much cash and debt does PASW have?
Ping An Biomedical Co. Ltd. reported CN¥1.17M in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does PASW stock trade?
Ping An Biomedical Co. Ltd. (PASW) is listed on NASDAQ.What sector and industry is PASW in?
Ping An Biomedical Co. Ltd. operates in the Consumer Discretionary sector, Apparel industry.When did Ping An Biomedical Co. Ltd. go public?
Ping An Biomedical Co. Ltd. (PASW) completed its IPO in 1999.What companies are similar to PASW?
Notable peers in the same industry include TPR (Tapestry Inc.), AS (Amer Sports Inc.), LULU (lululemon athletica inc.), LEVI (Levi Strauss & Co), GIL (Gildan Activewear Inc.). Compare PASW side-by-side with any of them on Quantisnow.How can I track PASW on Quantisnow?
Quantisnow aggregates Ping An Biomedical Co. Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PASW to receive live email and push alerts on every new disclosure.